Walleye Trading
LXRX icon

Walleye Trading’s Lexicon Pharmaceuticals LXRX Stock Holding History

Walleye Trading’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,100
Closed -$30K – 5168
2016
Q2 		$30K Sell
2,100
-3,800
-64% -$51.5K ﹤0.01% 4320
2016
Q1 		$71K Buy
5,900
+1,659
+39% +$17.4K ﹤0.01% 3620
2015
Q4 		$56K Buy
+4,241
New +$52.1K ﹤0.01% 3765

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Walleye Trading's LXRX Position: Q3 2016 in Review

Walleye Trading sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2016, closing a stake of 2,100 shares — an estimated $30K sold.

Walleye Trading first reported a position in LXRX in Q4 2015 and held it in 3 quarters. The position peaked at $71K in Q1 2016. 144 funds tracked by Wall St. Rank hold LXRX as of Q3 2016.

  • Walleye Trading reported no remaining Lexicon Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Walleye Trading sold 2,100 Lexicon Pharmaceuticals shares in Q3 2016, an estimated $30K.
  • Walleye Trading first reported a position in Lexicon Pharmaceuticals in Q4 2015 and held it in 3 quarters.
  • Walleye Trading's Lexicon Pharmaceuticals position peaked at $71K in Q1 2016.
  • 144 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2016.

Based on Walleye Trading's 13F filing for Q3 2016, filed 14 Nov 2016.